NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Amit, Ido Knolle, Percy Becher, Burkhard Llovet, Josep M. Weber, Achim Unger, Kristian Meissner, Felix Roth, Susanne Jilkova, Zuzana Macek Claassen, Manfred Anstee, Quentin M. Kaseb, Ahmed Kudo, Masatoshi Huang, Yi-Hsiang Djouder, Nabil Wolter, Katharina Zender, Lars Marche, Parice N. Schulz, Axel Ronald Ringelhan, Marc Malek, Nisar Spahn, Stephan Bitzer, Michael Ruiz de Galarreta, Marina Lujambio, Amaia Dufour, Jean-Francois Marron, Thomas U. Kutting, Fabian Waldschmidt, Dirk-Thomas Ebert, Matthias Philip Rahbari, Nuh Mei, Henrik E. Billeter, Adrian Mueller-Stich, Beat Kikuchi, Hiroto Duda, Dan G. Vogel, Arndt Peck-Radosavljevic, Markus Hucke, Florian Finkelmeier, Fabian Waidmann, Oliver Trojan, Jorg Schulze, Kornelius Wege, Henning Koch, Sandra Weinmann, Arndt Bueter, Marco Rossler, Fabian Siebenhuner, Alexander De Dosso, Sara Mallm, Jan-Philipp Umansky, Viktor Jugold, Manfred Luedde, Tom Schietinger, Andrea Schirmacher, Peter Emu, Brinda Augustin, Hellmut G. Scheiner, Bernhard Pomej, Katharina Kirstein, Martha M. Allison, Michael Bugianesi, Elisabetta Ratziu, Vlad Pressiani, Tiziana D'Alessio, Antonio Personeni, Nicola Rimassa, Lorenza Daly, Ann K. Tiniakos, Dina Bedossa, Pierre Cockell, Simon Younes, Ramy Vacca, Michele Marra, Fabio Schattenberg, Jorn M.
ISSN: 0168-8278 Pfister, Dominik Nunez, Nicolas Gonzalo Pinyol, Roser Govaere, Olivier Pinter, Matthias Szydlowska, Marta Gupta, Revant Qiu, Mengjie Deczkowska, Aleksandra Weiner, Assaf Mueller, Florian Sinha, Ankit Friebel, Ekaterina Engleitner, Thomas Lenggenhager, Daniela Moncsek, Anja Heide, Danijela Stirm, Kristin Kosla, Jan Kotsiliti, Eleni Leone, Valentina Dudek, Michael Yousuf, Suhail Inverso, Donato Singh, Indrabahadur Teijeiro, Ana Castet, Florian Montironi, Carla Haber, Philipp K. Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. (2020).Ĭopy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. (2019).Īn Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents. ISSN: 0007-0920 Moeini, Agrin Torrecilla, Sara Tovar, Victoria Montironi, Carla Andreu-Oller, Carmen Peix, Judit Higuera, Monica Pfister, Dominik Ramadori, Pierluigi Pinyol, Roser Sole, Manel Heikenwaelder, Mathias Friedman, Scott L. Molecular Portrait of High Alpha-Fetoprotein in Hepatocellular Carcinoma: Implications for Biomarker-Driven Clinical Trials. Platelet GPIb alpha is a mediator and potential interventional target for NASH and subsequent liver cancer. Unger, Kristian Zender, Lars Nieswandt, Bernhard Gawaz, Meinrad Weber, Achim Heikenwalder, Mathias (2019). Pinyol, Roser Tacke, Frank Rad, Roland Matter, Matthias Djouder, Nabil Kubes, Paul Knolle, Percy A.
Vegiopoulos, Alexandros Milsom, Michael D. Notohamiprodjo, Mike Geisler, Tobias Withers, Dominic J. Sheriff, Lozan Teijeiro, Ana Prinz, Marco Bogeska, Ruzhica Anstee, Natasha Bongers, Malte N.
Leslie, Jack O'Connor, Tracy Weston, Christopher J. Dauch, Daniel Kroy, Daniela Krenkel, Oliver Kohlhepp, Marlene Engleitner, Thomas Olkus, Alexander Sijmonsma, Tjeerd Volz, Julia Deppermann, Carsten Stegner, David Helbling, Patrick Nombela-Arrieta, Cesar Rafiei, Anahita Hinterleitner, Martina Rall, Marcel Baku, Florian Borst, Oliver Wilson, Caroline L. Rath, Dominik Ali, Adnan Wolf, Monika Julia Drescher, Hannah Healy, Marc E. Journal Publications Malehmir, Mohsen Pfister, Dominik Gallage, Suchira Szydlowska, Marta Inverso, Donato Kotsiliti, Elena Leone, Valentina Peiseler, Moritz Surewaard, Bas G.
0 kommentar(er)
